Portal del Investigador
Mex3a stemness signature as a predictive biomarker of clinical and pathological response to total neoadjuvant therapy in locally advanced rectal cancer
Más información
| Fecha de publicación: | 2024 |
| Objetivos: | To study the role of E2F3/ MEX3A in chemoradiotherapy resistance and in the prediction of neoadjuvant treatment response in patients with locally advanced rectal cancer |
| Instrumento: | Fondecyt Regular |
| Año de Inicio/Término: | 2024-2028 |
| Financiamiento/Sponsor: | CONICYT |
| Rol del Usuario: | COINVESTIGADOR(A) |
| DOI: |
1241269 |